Home›Stock Screener›TTK Healthcare›Intrinsic Value

TTK Healthcare Intrinsic Value

TTK Healthcare intrinsic value. TTK Healthcare (TTKHLTCARE) median intrinsic value is ₹1508.57 from 9 valuation models (range ₹316–₹2348), vs current price ₹1052.50 — +43.3% upside (Trading Below Calculated Value), margin of safety 30.2%. For current market price and key ratios, visit TTK Healthcare share price chart.

Market Price (CMP)
₹1052.50
Primary Intrinsic Value
₹2348.40
Market Cap
₹1474 Cr
+43.3% Upside
Median Value
₹1508.57
Value Range
₹316 - ₹2348
Assessment
Trading Below Calculated Value
Safety Margin
30.2%

TTKHLTCARE Valuation Methods Summary — DCF, Graham Number & P/E

TTK Healthcare intrinsic value across 9 models vs current price ₹1052.50 — upside/downside and value range per method. Analyse TTKHLTCARE institutional holdings to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹2348.40 ₹1878.72 - ₹2818.08 +123.1% EPS: ₹195.70, Sector P/E: 12x
Book Value Method asset ₹796.43 ₹716.79 - ₹876.07 -24.3% Book Value/Share: ₹796.43, P/B: 1.0x
Revenue Multiple Method revenue ₹709.14 ₹638.23 - ₹780.05 -32.6% Revenue/Share: ₹886.43, P/S: 0.8x
EBITDA Multiple Method earnings ₹1508.57 ₹1357.71 - ₹1659.43 +43.3% EBITDA: ₹352.00Cr, EV/EBITDA: 6x
PEG Ratio Method growth ₹1252.48 ₹1127.23 - ₹1377.73 +19.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹1663.95 ₹1497.56 - ₹1830.35 +58.1% Revenue Growth: 12.6%, Adj P/E: 8.5x
ROE Based Valuation profitability ₹2105.00 ₹1894.50 - ₹2315.50 +100.0% ROE: 24.8%, P/E Multiple: 16x
Graham Defensive Method conservative ₹1592.86 ₹1433.57 - ₹1752.15 +51.3% EPS: ₹195.70, BVPS: ₹796.43
Dividend Yield Method dividend ₹315.75 ₹284.18 - ₹347.33 -70.0% DPS: ₹10.00, Target Yield: 3.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

TTKHLTCARE Intrinsic Value vs Market Price — All Valuation Models

TTK Healthcare fair value range ₹316–₹2348 vs current market price ₹1052.50 across 9 valuation models. Browse TTK Healthcare financial data for revenue, profit, balance sheet and cash flow data.

TTKHLTCARE Intrinsic Value Analysis — Undervalued or Overvalued?

TTK Healthcare median intrinsic value ₹1508.57, current price ₹1052.50 — Trading Below Calculated Value by 43.3%, margin of safety 30.2%.

What is the intrinsic value of TTKHLTCARE?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of TTK Healthcare (TTKHLTCARE) is ₹1508.57 (median value). With the current market price of ₹1052.50, this represents a +43.3% variance from our estimated fair value.

The valuation range spans from ₹315.75 to ₹2348.40, indicating ₹315.75 - ₹2348.40.

Is TTKHLTCARE undervalued or overvalued?

Based on our multi-method analysis, TTK Healthcare (TTKHLTCARE) appears to be trading below calculated value by approximately 43.3%.

TTKHLTCARE Financial Health — Key Ratios vs Industry Benchmarks

TTK Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 24.8% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 3.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.93x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

TTKHLTCARE Cash Flow Quality — Operating & Free Cash Flow

TTK Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹-21 Cr ₹-21 Cr Negative Cash Flow 3/10
March 2025 ₹-4 Cr ₹-4 Cr Negative Cash Flow 3/10
March 2024 ₹-5 Cr ₹-5 Cr Negative Cash Flow 3/10
March 2023 ₹-25 Cr ₹-25 Cr Negative Cash Flow 3/10
March 2022 ₹45 Cr ₹30 Cr Positive Free Cash Flow 8/10